PET scan study for specific cancers using a new tracer
Part of Blood & lymphatic, Cancer, Lungs & breathing, Skin clinical trials.
This study uses a PET scan with a special radioactive tracer (68Ga-DOTA-Siglec-9) to look at cancer in certain people. It may help doctors better see cancer-related activity and guide treatment planning for selected cancers.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have one of these cancers: acute myeloid leukemia, metastatic melanoma, or metastatic stage IV non-small cell lung cancer
- You are able to follow your planned treatment plan for your cancer (transplant for AML, specific drug types for melanoma/NSCLC)
- You must be able and willing to sign informed consent in writing
- You must be able and willing to follow all study visit and scan instructions
- You should not have major uncontrolled health problems affecting the brain, kidneys, liver, hormones, or gut
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new PET imaging agent, [18F]AlF-NOTA-PCP2, to detect PD-L1 protein in tumors. It may help guide treatment decisions for people with glioblastoma, head and neck, lung, or esophageal cancer.
This study tests a new imaging technique using a special tracer (68Ga-DOTA-BLP) that may help spot cancer more accurately. It is for people with confirmed cancer who have suspicious lymph nodes or possible spread, and who have not yet started cancer treatment.
This trial uses a special PET scan to see how well it can find and track different types of cancer. It may help doctors better understand your cancer.
This study uses a new imaging tracer, called 68Ga-SorB, during a PET/CT scan to look at tumors. It may help doctors see cancer more clearly. The trial is for adults with certain types of solid tumors (such as melanoma, liver, lung, breast, pancreatic, ovarian, or bile duct cancer) who need a PET/CT scan as part of their care.
This trial tests a new PET imaging agent that targets CD73, a protein found on many cancer cells. It may help doctors see tumors more clearly without chemotherapy or radiation before the scan.
This study tests a special PET scan called 68Ga-DOTATOC to see if it can find certain breast cancer cells in the body. It may help doctors better understand your cancer, especially if it has spread to the liver or bones.
Hear when a new Acute Myeloid Leukemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.